ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      84.175
      0.69%
      Bitcoin
      66,964.81
      1.22%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Harmony Biosciences Holdings Inc (HRMY)

      7. Harmony Biosciences Holdings Inc (HRMY) News

      HRMY

      Harmony Biosciences (HRMY)

      Harmony Biosciences Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:HRMY
      DateTimeSourceHeadlineSymbolCompany
      04/30/20247:05AMGlobeNewswire Inc.Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare EpilepsyNASDAQ:HRMYHarmony Biosciences Holdings Inc
      04/30/20247:00AMPR Newswire (US)Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS AssetsNASDAQ:HRMYHarmony Biosciences Holdings Inc
      04/16/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
      04/11/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTNASDAQ:HRMYHarmony Biosciences Holdings Inc
      04/03/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
      03/26/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
      03/11/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      03/08/20244:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/28/20245:16PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/28/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESNASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/22/20244:14PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/22/20248:00AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/22/20248:00AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/22/20247:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/22/20247:30AMGlobeNewswire Inc.Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/21/20248:05AMPR Newswire (US)U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSYNASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/20/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/13/20247:06PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
      02/08/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/26/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/26/20244:58PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/26/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/26/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/08/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/08/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCENASDAQ:HRMYHarmony Biosciences Holdings Inc
      01/03/20248:05AMPR Newswire (US)HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
      12/07/20234:06PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
      12/07/20238:05AMPR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1NASDAQ:HRMYHarmony Biosciences Holdings Inc
      12/05/20238:05AMPR Newswire (US)HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETINGNASDAQ:HRMYHarmony Biosciences Holdings Inc
      11/16/20238:05AMPR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:HRMY